State of Alaska Department of Revenue Sells 3,535 Shares of CME Group Inc. (NASDAQ:CME)

State of Alaska Department of Revenue trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME) by 6.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 47,362 shares of the financial services provider’s stock after selling 3,535 shares during the period. State of Alaska Department of Revenue’s holdings in CME Group were worth $10,450,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Pullen Investment Management LLC raised its stake in CME Group by 1.8% in the 3rd quarter. Pullen Investment Management LLC now owns 7,229 shares of the financial services provider’s stock valued at $1,595,000 after acquiring an additional 128 shares during the period. Capital Advisors Ltd. LLC raised its stake in CME Group by 4.9% in the 3rd quarter. Capital Advisors Ltd. LLC now owns 1,251 shares of the financial services provider’s stock valued at $276,000 after acquiring an additional 58 shares during the period. Hamlin Capital Management LLC raised its stake in CME Group by 16.2% in the 3rd quarter. Hamlin Capital Management LLC now owns 744,690 shares of the financial services provider’s stock valued at $164,316,000 after acquiring an additional 103,959 shares during the period. Clear Harbor Asset Management LLC raised its stake in CME Group by 0.5% in the 3rd quarter. Clear Harbor Asset Management LLC now owns 36,171 shares of the financial services provider’s stock valued at $7,981,000 after acquiring an additional 168 shares during the period. Finally, Smith Salley Wealth Management raised its stake in CME Group by 3.1% in the 3rd quarter. Smith Salley Wealth Management now owns 8,025 shares of the financial services provider’s stock valued at $1,771,000 after acquiring an additional 240 shares during the period. 87.75% of the stock is currently owned by institutional investors.

CME Group Stock Down 1.5 %

Shares of NASDAQ CME opened at $226.14 on Monday. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.36. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The firm has a market capitalization of $81.43 billion, a price-to-earnings ratio of 25.73, a PEG ratio of 7.76 and a beta of 0.55. The business has a 50-day moving average of $218.94 and a 200-day moving average of $208.87.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the previous year, the firm earned $2.25 earnings per share. CME Group’s revenue was up 18.4% on a year-over-year basis. Sell-side analysts expect that CME Group Inc. will post 10.04 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.03%. The ex-dividend date was Monday, September 9th. CME Group’s payout ratio is 52.33%.

Insiders Place Their Bets

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on CME. Redburn Atlantic cut CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective on the stock. in a research note on Tuesday, October 8th. TD Cowen began coverage on CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 price objective on the stock. Piper Sandler boosted their price objective on CME Group from $225.00 to $240.00 and gave the company an “overweight” rating in a research note on Tuesday, October 8th. Morgan Stanley lifted their target price on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a report on Thursday, October 17th. Finally, Oppenheimer lifted their target price on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a report on Thursday. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $222.07.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.